Common Contracts
4 similar Asset Purchase Agreement contracts by Bluebird Bio, Inc., Argenx Se
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • October 30th, 2023 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances) • New York
This ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of October 26, 2023 (the “Effective Date”), by and between bluebird bio, Inc., a corporation organized under the laws of Delaware (“Seller”), and Novartis Pharma AG, an entity organized under the laws of Switzerland (“Buyer”). Buyer and Seller may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • January 6th, 2023 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances) • Delaware
This ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of January 5, 2023 (the “Effective Date”), by and between bluebird bio, Inc., a corporation organized under the laws of Delaware (“Seller”), and Bristol-Myers Squibb Company, a corporation incorporated under the laws of Delaware (“Buyer”). Buyer and Seller may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • November 30th, 2022 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of November 29, 2022 (the “Effective Date”), by and between Bluebird Bio, Inc., a corporation organized under the laws of Delaware (“Seller”), and ARGENX BV, a limited liability company organized under the laws of Belgium (“Buyer”). Buyer and Seller may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • November 30th, 2022 • Argenx Se • Biological products, (no disgnostic substances) • Massachusetts
This ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of November 29, 2022 (the “Effective Date”), by and between Bluebird Bio, Inc., a corporation organized under the laws of Delaware (“Seller”), and ARGENX BV, a limited liability company organized under the laws of Belgium (“Buyer”). Buyer and Seller may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.
